e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictors of survival in idiopathic interstitial pneumonia
R. Carbone, M. Grosso, F. Montanaro, A. Monselise, D. Cantalupi, G. Bottino, E. Balleari, R. Ghio (Aosta, Genoa, Italy; Tel Aviv, Israel)
Source:
Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session:
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session type:
Thematic Poster Session
Number:
815
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Carbone, M. Grosso, F. Montanaro, A. Monselise, D. Cantalupi, G. Bottino, E. Balleari, R. Ghio (Aosta, Genoa, Italy; Tel Aviv, Israel). Predictors of survival in idiopathic interstitial pneumonia. Eur Respir J 2007; 30: Suppl. 51, 815
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017
Quantifying risk of mortality in idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 149s
Year: 2001
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
High short-term mortality following lung biopsy for usual interstitial pneumonia
Source: Eur Respir J 2001; 17: 175-179
Year: 2001
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Smoking-related idiopathic interstitial pneumonia
Source: Eur Respir J 2014; 44: 594-602
Year: 2014
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Causes of chronic cough in patients with interstitial pneumonia
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008
Non-IPF idiopathic interstitial pneumonias
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013
Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival
Source: Eur Respir J, 56 (3) 1902292; 10.1183/13993003.02292-2019
Year: 2020
Severity before or at the onset of acute exacerbation (AE) can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs)?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018
Year: 2018
Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002
Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience
Source: International Congress 2014 – ILDs 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept